Works matching IS 13419625 AND DT 2019 AND VI 24 AND IP 10

Results: 19
    1
    2

    Immune checkpoint inhibitor-induced sarcoidosis-like granulomas.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1171, doi. 10.1007/s10147-019-01490-2
    By:
    • Rambhia, Pooja H.;
    • Reichert, Barbara;
    • Scott, Jeffrey F.;
    • Feneran, Ashley N.;
    • Kazakov, Jordan A.;
    • Honda, Kord;
    • Koon, Henry;
    • Gerstenblith, Meg R.
    Publication type:
    Article
    3
    4

    Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1182, doi. 10.1007/s10147-019-01479-x
    By:
    • Kibe, Yuichi;
    • Nakamura, Naoki;
    • Kuno, Hirofumi;
    • Hiyama, Takashi;
    • Hayashi, Ryuichi;
    • Zenda, Sadamoto;
    • Motegi, Atsushi;
    • Hojo, Hidehiro;
    • Nakamura, Masaki;
    • Ariji, Takaki;
    • Oyoshi, Hajime;
    • Akimoto, Tetsuo
    Publication type:
    Article
    5

    Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1247, doi. 10.1007/s10147-019-01478-y
    By:
    • Aizawa, Rihito;
    • Takayama, Kenji;
    • Nakamura, Kiyonao;
    • Inoue, Takahiro;
    • Yamasaki, Toshinari;
    • Kobayashi, Takashi;
    • Akamatsu, Shusuke;
    • Ogawa, Osamu;
    • Mizowaki, Takashi
    Publication type:
    Article
    6
    7

    A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1320, doi. 10.1007/s10147-019-01476-0
    By:
    • Hattori, Masaya;
    • Hagiwara, Sumitaka;
    • Kotani, Haruru;
    • Tatematsu, Michiko;
    • Tachi, Masahiko;
    • Hijioka, Susumu;
    • Shimizu, Junichi;
    • Andoh, Masashi;
    • Mizuno, Yasunari;
    • Sawaki, Masataka;
    • Yoshimura, Akiyo;
    • Gondo, Naomi;
    • Adachi, Yayoi;
    • Yoshimura, Kenichi;
    • Iwata, Hiroji
    Publication type:
    Article
    8
    9
    10

    Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1223, doi. 10.1007/s10147-019-01473-3
    By:
    • Suzuki, Nobuaki;
    • Hazama, Shoichi;
    • Nagasaka, Takeshi;
    • Tanioka, Hiroaki;
    • Iwamoto, Yasuo;
    • Negoro, Yuji;
    • Yamauchi, Masami;
    • Kobayashi, Michiya;
    • Okuda, Hiroshi;
    • Fujishima, Noriaki;
    • Nishimura, Taku;
    • Yamanaka, Naoki;
    • Toyota, Kazuhiro;
    • Mori, Yoshiko;
    • Nakagami, Yuki;
    • Shimokawa, Mototsugu;
    • Nagano, Hiroaki;
    • Okajima, Masazumi
    Publication type:
    Article
    11
    12

    A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1284, doi. 10.1007/s10147-019-01471-5
    By:
    • Fujiwara, Hiroyuki;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Takano, Masashi;
    • Yoshino, Kiyoshi;
    • Kawano, Yoshiaki;
    • Hirashima, Yasuyuki;
    • Nagase, Satoru;
    • Nishio, Shin;
    • Nishikawa, Tadaaki;
    • Ito, Kimihiko;
    • Shoji, Tadahiro;
    • Kimura, Eizo;
    • Takano, Tadao;
    • Sugiyama, Toru;
    • Kigawa, Junzo;
    • Fujiwara, Keiichi;
    • Suzuki, Mitsuaki
    Publication type:
    Article
    13
    14
    15

    Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1214, doi. 10.1007/s10147-019-01465-3
    By:
    • Moriwaki, Toshikazu;
    • Sakai, Yoshinori;
    • Ishida, Hiroyasu;
    • Yamamoto, Yoshiyuki;
    • Endo, Shinji;
    • Kuramochi, Hideaki;
    • Sato, Mikio;
    • Hatachi, Yukimasa;
    • Bando, Yoshiaki;
    • Maeba, Takashi;
    • Ikezawa, Kazuto;
    • Shimada, Mitsuo;
    • Amagai, Kenji;
    • Morimoto, Masamitsu;
    • Kobayashi, Kazuma;
    • Tsuji, Akihito;
    • Nishina, Tomohiro;
    • Hyodo, Ichinosuke
    Publication type:
    Article
    16
    17
    18
    19

    Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1204, doi. 10.1007/s10147-019-01460-8
    By:
    • Sasaki, Shun;
    • Oki, Eiji;
    • Saeki, Hiroshi;
    • Shimose, Takayuki;
    • Sakamoto, Sanae;
    • Hu, Qingjiang;
    • Kudo, Kensuke;
    • Tsuda, Yasuo;
    • Nakashima, Yuichiro;
    • Ando, Koji;
    • Akagi, Yoshito;
    • Kakeji, Yoshihiro;
    • Baba, Hideo;
    • Maehara, Yoshihiko
    Publication type:
    Article